Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06611410 · ClinicalTrials.gov registry record · NA
1 Week Crossover Study Between Two Soft Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT06611410 is a NA study that has completed, run by CooperVision. The registered enrollment target is 10 participants.
The verdict
NCT06611410, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this investigation is to compare the visual clinical performance of two daily disposable soft contact lenses.
Interventions
- DEVICE Test Lenses (stenfilcon A)
- DEVICE Control Lenses (omafilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2024-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06611410
The ClinicalTrials.gov registry entry for NCT06611410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Test Lenses (stenfilcon A) is the first listed.
NCT06611410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06611410 about?
NCT06611410 is a clinical study titled "1 Week Crossover Study Between Two Soft Contact Lenses". The objective of this investigation is to compare the visual clinical performance of two daily disposable soft contact lenses.
What is the current status of trial NCT06611410?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-06-05. Estimated completion is 2024-07-26.
What interventions are being tested in trial NCT06611410?
The interventions under investigation include: Test Lenses (stenfilcon A) (DEVICE), Control Lenses (omafilcon A) (DEVICE).
Who is sponsoring clinical trial NCT06611410?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.